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  The Nordic Arthroplasty Register Association (NARA) was 
established in 2007 by arthroplasty register representatives 
from Sweden, Norway and Denmark with the overall aim 
to improve the quality of research and thereby enhance 
the possibility for quality improvement with arthroplasty 
surgery. Finland joined the NARA collaboration in 2010.
  NARA minimal hip, knee and shoulder datasets were cre-
ated with variables that all countries can deliver. They 
are dynamic datasets, currently with 25 variables for hip 
arthroplasty, 20 for knee arthroplasty and 20 for shoulder 
arthroplasty.
  NARA has published statistical guidelines for the analysis 
of arthroplasty register data. The association is continu-
ously working on the improvement of statistical methods 
and the application of new ones.
  There are 31 published peer-reviewed papers based on 
the NARA databases and 20 ongoing projects in differ-
ent phases. Several NARA publications have significantly 
affected clinical practice. For example, metal-on-metal 
total hip arthroplasty and resurfacing arthroplasty have 
been abandoned due to increased revision risk based on 
i.a. NARA reports. Further, the use of uncemented total hip 
arthroplasty in elderly patients has decreased significantly, 
especially in Finland, based on the NARA data.
  The NARA collaboration has been successful because the 
countries were able to agree on a common dataset and 
variable definitions. The collaboration was also success-
ful because the group was able to initiate a number of 
research projects and provide answers to clinically relevant 
questions. A number of specific goals, set up in 2007, have 
been achieved and new one has emerged in the process.
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Introduction
The Nordic countries, including Denmark, Sweden, Fin-
land and Norway, all have a long and successful tradition 
of arthroplasty registers. These registers are characterized 
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by high research activity with a focus on improving the 
quality of care for patients undergoing arthroplasty sur-
gery. However, the results presented by the Nordic regis-
ters have suggested differences among the countries 
related to variations in data collection systems, variables 
that are included, variable definitions and statistical meth-
ods used. Reports from the Nordic registers have further 
shown differences regarding the incidence and indication 
for surgery, characteristics of the joint replacement popu-
lations, implants used, fixation methods used and implant 
survival. Due to these differences, the results from the dif-
ferent Nordic registers have not been fully comparable. 
Furthermore, although the Nordic registers are population-
based, the number of patients included in specific sub-
populations (e.g. patients that have undergone joint 
replacement due to rheumatoid arthritis (RA) or patients 
operated due to osteonecrosis) or the number of patients 
incurring specific adverse events after surgery (e.g. revi-
sion due to infection or periprosthetic fracture) are rela-
tively small, which limits the statistical precision of risk 
estimates and the possibility to draw valid conclusions.
The Nordic registers have acknowledged these limita-
tions and the need for collaboration across national bor-
ders in order to create common databases, which 
complete the limitations from each register. Thus, NARA 
was established in 2007 by arthroplasty register repre-
sentatives from Sweden, Norway and Denmark. Finland 
joined the NARA collaboration in 2010. The aim of NARA is 
to improve the quality of research and understanding of 
the clinical course of patients undergoing joint replace-
ment surgery and thereby improve the results after joint 
replacement surgery.
In order to achieve the overall aim of NARA, several spe-
cific aims were set. The basic prerequisite for the collabo-
rative work was to create common Nordic minimal 
datasets in hip, knee and shoulder arthroplasty. With the 
common datasets, we are able to compare demographics 
and results of joint replacement surgery among countries, 
and study results in patient groups, which are too small to 
be studied in each separate country. NARA aims to pro-
mote joint Nordic research on specific problems of com-
mon interest. Collaboration between the different national 
research teams and compilation of big datasets will con-
tribute to a higher quality of the analyses performed. 
Another specific aim of NARA is to discuss and agree upon 
methodology and coordinate quality improvements as 
regards data capture and analyses. In addition, NARA also 
coordinates a joint Nordic standpoint towards other inter-
national register associations.
The NARA steering committee and other representa-
tives from each member country are responsible for over-
seeing the aims and directing the NARA work. Nowadays, 
NARA has at least two face-to-face meetings yearly, in 
addition to frequent teleconferences and web-meetings. 
NARA consists of people with different academic back-
ground, including orthopaedic surgeons, epidemiolo-
gists, biostatisticians, PhD students, software developers 
and registry coordinators. The registers currently involved 
in NARA are the Danish Hip Arthroplasty Register, the Dan-
ish Knee Arthroplasty Register, the Danish Shoulder 
Arthroplasty Register, the Finnish Arthroplasty Register, 
the Norwegian Arthroplasty Register, the Swedish Hip 
Arthroplasty Register, the Swedish Knee Arthroplasty Reg-
ister and the Swedish Shoulder Arthroplasty Register.
The aim of this paper is to describe the NARA collabora-
tion and review a selection of published NARA projects.
Material and methods
Description of the NARA datasets
The NARA datasets include only variables that all countries 
can deliver. They are dynamic minimal datasets currently 
including 25 variables for hip arthroplasty, 20 for knee 
arthroplasty and 20 for shoulder arthroplasty. Once a year, 
we merge updated data from all registers to be used for 
approved projects. The set of variables are closely reviewed 
and any changes are discussed in the steering committee.
The NARA dataset include all primary hip, knee and 
shoulder arthroplasty procedures performed in Norway, 
Denmark, Sweden and Finland since 1995 for hip proce-
dures, since 1997 for knee procedures, and since 2004 for 
shoulder procedures. Revision operations are linked to pri-
mary procedures in the respective national registries. 
National data are subsequently anonymized and trans-
ferred to the common NARA dataset. In all countries, a 
revision procedure is defined as a surgical procedure 
including exchange, removal or addition of any implant 
component.
Statistical analyses
NARA has published statistical guidelines for the analysis 
of arthroplasty data in registers. The guidelines are divided 
into two parts: one with an introduction and a discussion 
of the background for the guidelines; and one with a more 
technical statistical discussion on how specific problems 
can be handled. The first part contains: (1) recommenda-
tions for the interpretation of methods used to calculate 
survival; (2) recommendations on how to deal with bilat-
eral observations; and (3) a discussion of problems and 
pitfalls associated with analysis of factors that influence 
survival or comparisons between outcomes extracted 
from different hospitals.1
The second part addresses methodological issues 
including recommendations about: (1) competing risk 
problems; (2) detecting and handling departures from the 
proportional hazards assumption; (3) bilateral observa-
tions; and (4) revision rate ranking.2
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The projects performed using NARA data have to a 
large extent applied these statistical methods. The group 
is continuously working on the improvement of statistical 
methods and the application of new ones, including pro-
pensity score matching in order to reduce confounding, 
the multiple imputation method which deals with the 
problem of missing data and the pseudo value approach 
when taking death as a competing risk into account in 
order to assess the relative risk.
Validity methods used in NARA
The Nordic countries are world-leading in the field of 
international quality registers. The results derived from 
Nordic hip, knee and shoulder registers are frequently 
cited in the international literature and considered to be 
‘role models’ for the efforts to initiate similar registries in 
other countries. Key points for national registries to have 
success are relatively small size of the countries - 4.5 to 10 
million inhabitants - with uniform healthcare systems, and 
systems to assign unique personal identity numbers to 
each citizen, enabling unambiguous linkage within and 
between registers. Regular rigorous validation processes 
within the participating registers are prerequisites for high 
data quality.
For national registers to have success, it is also neces-
sary to be able to follow-up all patients to their death, emi-
gration or reoperation, and to link the index operation to 
all types of complications and outcomes. Ability to link the 
database to registers such as National Patient Registers, 
National Cancer Registers, National Registers for Socioeco-
nomic data and National Prescription database are also of 
high importance.
The validity of registers is one of the most important 
tasks which each national register is continuously work-
ing on. The validity consists of four major aspects, includ-
ing: (1) coverage of registers is defined as the proportion 
of hospitals/departments contributing to the registration 
of cases to the national register out of the total number of 
hospitals/departments performing arthroplasty proce-
dures in the country; (2) registration completeness of 
operations in a register is defined as the proportion of 
arthroplasty operations registered in the database out of 
the total number of operations performed in the country 
(where the total number is defined by a combination of 
data on all procedures reported to the respective National 
Patient Register and the respective arthroplasty register); 
(3) registration completeness of variables: although an 
operation may be reported to the register, it is further 
important that all variables included in the registration 
form are reported for each operation; and (4) it is not only 
important that all variables are reported, but also that the 
values of these variables are accurately reported. Accu-
racy of registered variables is defined as the probability 
that variables registered in the national register are cor-
rectly registered and present what is supposed to 
present.
In practice, all orthopaedic departments in the Nordic 
countries report to the national registers, including pri-
vate hospitals. Thus, the coverage of Nordic hospitals in 
the NARA database is 100%. The registration complete-
ness of arthroplasty procedures in Nordic national regis-
ters is compared with the registration completeness in the 
Nordic patient registers. Registration completeness of pri-
mary arthroplasty procedures is in the range of 90% to 
98%, and that of revision arthroplasty 85% to 94% in the 
four countries. However, the Finnish Arthroplasty Register 
has completeness of only 60% for shoulder arthroplasty 
due to missing many fracture patients. Up-to-date regis-
tration completeness of each register can be found in the 
most current annual reports.
Review of selected NARA projects
Hip arthroplasty
The first peer-reviewed scientific paper from the NARA 
group was published by Havelin et al. (2009). They 
assessed 280,201 primary total hip arthroplasty (THA) 
procedures performed in Sweden, Norway and Denmark 
from 1995 to 2006. Cemented THAs were used in 46% of 
patients in Denmark, in 89% of patients in Sweden and in 
79% of patients in Norway. Of the 280 201 primary THAs, 
9596 (3.4%) had been revised. Calculating ten-year 
Kaplan–Meier estimates, implant survival was 92% (95% 
confidence interval (CI) 91.6 to 92.4) in Denmark, 94% 
(95% CI 93.6 to 94.1) in Sweden and 93% (95% CI 92.3 
to 93.0) in Norway (Fig. 1).3
Focus on metal-on-metal hip devices
Johanson et al (2010) compared 1638 hip resurfacing 
arthroplasties in Sweden, Norway and Denmark with 
172 554 conventional THA. They found an almost three-
fold increased revision risk for hip resurfacing arthroplas-
ties (HRA) compared with THA (relative risk (RR) 2.7, 95% 
CI 1.9 to 3.7), The difference was even greater when HRA 
was compared with the THA subgroup of cemented THAs 
(RR 3.8, 95% CI 2.7 to 5.3). For men aged < 50 years, this 
difference was less pronounced (HRA vs THA: RR 1.9, 95% 
CI 1.0 to 3.9; HRA vs cemented THA: RR 2.4, 95% CI 1.1 to 
5.3), but it was even more pronounced in women of the 
same age group (HRA vs THA: RR 4.7, 95% CI 2.6 to 8.5; 
HRA vs cemented THA: RR 7.4, 95% CI 3.7 to 15). The 
authors concluded that their results did not support con-
tinued use of HRA.4
Varnum et al (2015) assessed 32 678 patients who 
were operated from 2002 through 2010 with cementless 
stemmed THA with either metal-on-metal bearings 
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(11 567 patients, 35%) or metal-on-polyethylene bear-
ings (21 111 patients, 65%). The cumulative incidence of 
revision at eight years of follow-up was 7.0% (95% CI 6.0 
to 8.1) for metal-on-metal bearings and 5.1% (95% CI 4.7 
to 5.6) for metal-on-polyethylene bearings. They con-
cluded that at medium-term follow-up, the survivorship 
for cementless stemmed metal-on-metal THA was inferior 
to that for metal-on-polyethylene THA. Further, metal-
related problems may cause even higher revision rates for 
metal-on-metal bearings with longer follow-up (Fig. 2)5.
Focus on fixation methods of primary THA
Pedersen et al assessed 29 558 primary THRs on patients 
with osteoarthritis (OA), aged < 55 years, performed from 
1995 to 2011 based on the NARA database. They stated 
that uncemented implants performed better with respect 
to long-term risk of aseptic loosening in patients aged < 
55 years. However, uncemented and hybrid THAs had 
more short-term revisions compared with cemented 
implants due to dislocation, periprosthetic fracture and 
infection.6
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Fig. 1 Kaplan-Meier estimated curves until revision for any cause, for primary total hip replacements (THAs) in Denmark, Sweden, 
and Norway 1995–2006. Curves are given for all THAs and also for those classified according to fixation technique as cemented, 
uncemented, and hybrids (uncemented cup/cemented stem).
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Concerning the THA fixation in elderly patients, Mäkelä 
et al assessed 347 899 THRs performed during 1995 to 
2011 based on the NARA database. They found that the 
proportion of total hip replacements using uncemented 
implants increased rapidly towards the end of the study 
period. The ten-year survival of cemented implants in 
patients aged 65 to 74 years and ⩾ 75 years (93.8%, 95% 
CI 93.6 to 94.0 and 95.9%, 95% CI 95.8 to 96.1, respec-
tively) was higher than that of uncemented (92.9%, 95% 
CI 92.3 to 93.4 and 93.0%, 95% CI 91.8 to 94.0), hybrid 
(91.6%, 95% CI 90.9 to 92.2 and 93.9%, 95% CI 93.1 to 
94.5) and reverse hybrid (90.7%, 95% CI 87.3 to 93.2 and 
93.2%, 95% CI 90.7 to 95.1) implants. During the first six 
months, the risk of revision with cemented implants was 
lower than with all other types of fixation in all age groups. 
They concluded that implant survival for cemented 
implants was higher compared with uncemented implants 
in patients aged ⩾ 65 years. The increased use of unce-
mented implants in this age group identified in the NARA 
countries was not supported by these results.7
The association between hydroxyapatite (HA) coating 
and revision risk has been investigated for both acetabular 
and femoral components. Hailer et al found that the pres-
ence of HA coating on the femoral stem did not alter risk 
of stem revision due to aseptic loosening (hazard ratio 
(HR) 0.8, 95% CI 0.5 to 1.3). They concluded that unce-
mented HA-coated stems had similar results to those of 
uncemented stems with porous coating and rough sand-
blasted stems. The use of HA coating on stems that were 
available both with and without this surface treatment 
had no clinically relevant effect on their outcome (Fig. 3).8 
Lazarinis et al investigated three different cup types with 
or without HA coating that were inserted due to OA 
(n = 28 605). Thirteen-year survival for cup revision due to 
aseptic loosening was 97.9% (95% CI 96.5 to 99.4) for 
uncoated and 97.8% (95% CI 96.3 to 99.4) for HA-coated 
cups. Since HA-coated cups had a similar risk of aseptic 
loosening as uncoated cups, the authors suggested the 
use of HA coating does not confer any added value in 
terms of implant stability.9
Focus on total joint infections
Dale et al assessed THAs revised due to infection from 
1995 to 2009. In total, 2778 (0.6%) of the primary THAs 
were revised due to infection. Compared with the period 
1995 to 1999, the risk of revision due to infection was 1.1 
(95% CI 1.0 to 1.2) in 2000 to 2004 and 1.6 (95% CI 1.4 
to 1.7) in 2005 to 2009. No change in risk factors in the 
NARA dataset could explain this increase. The authors sug-
gested that there has been an actual increase in the inci-
dence of prosthetic joint infections after THA.10
Schrama et al assessed 13 384 patients undergoing 
THA due to RA and 377 287 patients undergoing THA due 
to OA from 1995 to 2010. They found a slightly higher 
overall risk of revision for infection in RA patients than in 
patients with OA, but the difference was only present after 
2001. In THAs with antibiotic-loaded cement, the risk of 
very early and late infections leading to revision was 
higher in RA compared with OA patients11.
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Fig. 2 Cumulative incidence for any revision of cementless 
total hip arthroplasty with metal-on-metal (MoM) bearings and 
metal-on-polyethylene (MoP) bearings.
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Fig. 3 Survival of non-HA-coated and HA-coated Bimetric stems 
for females aged 60–74 with a diagnosis of osteoarthritis, with 
the endpoint stem revision for aseptic loosening in an adjusted 
Cox regression model.
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Focus on periprosthetic fractures of the hip
Thien et al used the NARA database to evaluate whether 
age, sex, preoperative diagnosis, fixation and implant 
design influence the risk of revision arthroplasty due to 
periprosthetic fracture within two years from operation of 
a primary THR. A total of 325 730 cemented femoral stems 
and 111 899 uncemented femoral stems inserted from 
1995 to 2009 were included. Seven frequently used stems 
(two cemented stems (Exeter and Lubinus SP II) and five 
uncemented stems (Bi-Metric, Corail, CLS Spotorno, ABG 
I, and ABG II)) were specifically studied. The authors 
observed that the risk for revision due to early peripros-
thetic fracture increased during the period 2003 to 2009 
compared with the period 1995 to 2002, both before and 
after adjustment for demographic factors and fixation (RR 
1.4, 95% CI 1.2 to 1.7). Uncemented implants had more 
periprosthetic fractures than cemented ones, especially in 
the older age groups.12
Focus on hip diagnosis
Engesæter et al compared the survival of primary THAs 
performed during the period 1995 to 2009 due to child-
hood hip disease (developmental dysplasia of the hip, 
slipped capital femoral epiphysis, Perthes’ disease) with 
primary OA. After adjustment for differences in age, sex, 
and type of fixation of the prosthesis, no difference in the 
risk of revision was found for primary THAs performed due 
to paediatric hip diseases and those performed due to pri-
mary OA.13
Bergh et al assessed 416 217 hips with primary OA and 
11 589 with femoral head necrosis. After adjusting for 
covariates, the relative risk of revision for any reason was 
higher in patients with femoral head necrosis for both 
periods studied (up to two years: RR 1.4, 95% CI 1.3 to 1.5 
and 2 to 16 years: RR 1.25, 95% CI 1.1 to 1.4). They 
concluded that the increased risk persisted over the entire 
period of observation and that all of the four most com-
mon reasons for revision were more frequent in the femo-
ral head necrosis cases.14
Focus on structural indicators
Glassou et al examined if hospital procedure volume was 
associated with the risk of revision after primary THA in the 
Nordic countries from 1995 to 2011. This study showed a 
consistent and strong association between hospital proce-
dure volume and long-term risk of revision after primary 
THA - primarily based on an association in the large group 
of cemented THAs. Hospitals with < 50 procedures per 
year had an increased risk of revision at two, five, ten and 
15 years after primary cemented THA. There may also be 
an association between hospital volume and the risk of 
revision in uncemented THAs; however, based on this 
study the association seems less pronounced.15
Five years after the first NARA report on ten-year THA 
survival, Mäkelä et al reported the 15-year survival for 
THAs, with the use of any revision as endpoint. In Den-
mark, it was 86% (95% CI 86 to 87), in Sweden, it was 
88% (95% CI 88 to 88), in Norway, it was 87% (95% CI 87 
to 87) and in Finland, it was 84% (95% CI 83 to 84). The 
observed differences with a maximum of 4% were 
regarded as considerable and could at least partly be 
explained by different implant selection (Fig. 4).16
Focus on methods and implant brands
Wangen et al extracted data on reverse hybrid THAs from 
1 January 2000 until 31 December 2013 from the NARA 
database. A total of 38 415 such hips were studied and 
compared with cemented THAs. The authors found a 
higher rate of revision for reverse hybrids than for 
cemented THAs, with an adjusted relative risk of revision 
(RR) of 1.4 (95% CI 1.3 to 1.5). At ten years, the survival 
rate was 94% (95% CI 94 to 95) for cemented THAs and 
92% (95% CI 92 to 93) for reverse hybrids. The results for 
the reverse hybrid THAs were inferior to those for cemented 
THAs in patients aged ⩾ 55 years (RR 1.1, 95% CI 1.0 to 
1.3; p < 0.05). They found a higher rate of early revision 
due to periprosthetic femoral fracture for reverse hybrids 
than for cemented THAs in patients aged ⩾ 55 years (RR 
3.1, 95% CI 2.2 to 4.5; p < 0.001). The authors concluded 
that reverse hybrid THAs had a slightly higher rate of revi-
sion than cemented THAs in patients aged ⩾ 55. The dif-
ference in survival was mainly caused by a higher incidence 
of early revision due to periprosthetic femoral fracture in 
the reversed hybrid THAs (Fig. 5).17
Junnila et al performed a brand-level comparison of 
cemented THAs based on the NARA database. They found 
that Spectron EF THA (89.9% (95% CI 89.3 to 90.5)) and 
Elite THA (89.8% (95% CI 89.0 to 90.6)) had the lowest 
ten-year survivorship. Lubinus (95.7% survival, 95% CI 
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Fig. 4 Kaplan-Meier survival for all total hip replacements in 
the NARA database (by country), with any reason for revision as 
endpoint.
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95.5 to 95.9), MS 30 (96.6%, 95% CI 95.8 to 97.4) and 
C-stem THA (95.8%, 95% CI 94.8 to 96.8) had a ten-year 
survivorship of at least 95%. Lubinus (RR 0.77, 95% CI 0.73 
to 0.81), Müller (RR 0.83, 95% CI 0.70 to 0.99), MS-30 (RR 
0.73, 95% CI 0.63 to 0.86), C-stem (RR 0.70, 95% CI 0.55 
to 0.90) and Exeter Duration THA (RR 0.84, 95% CI 0.77 to 
0.90) had a lower risk of revision than Charnley THA, the 
reference implant. The authors concluded that the Spec-
tron EF THA and the Elite THA had a lower implant survival 
than the Charnley, Exeter and Lubinus THAs. Implant sur-
vival of the Müller, MS 30, CPT and C-stem THAs was 
above the acceptable limit for ten-year survival.18
Johanson et al compared the risk of cup and/or liner 
revision for specific cup and liner designs made of either 
cross-linked polyethylene (XLPE) or conventional poly-
ethylene (CPE), regarding revision for any reason and 
revision due to aseptic loosening and/or osteolysis. 
They found that the CPE version of the ZCA cup had a 
risk of revision for any reason similar to that of the XLPE 
version (p = 0.09) but showed a sixfold higher risk of 
revision for aseptic loosening (p < 0.001). The CPE ver-
sion of the Reflection All Poly cup had an eightfold ele-
vated risk of revision for any reason (p < 0.001) and a 
fivefold increased risk of revision for aseptic loosening 
(p < 0.001). The Charnley Elite Ogee/Marathon cup and 
the Trilogy cup did not show such differences. The 
authors concluded that whether XLPE has any advan-
tage over CPE regarding revision risk may depend on 
the properties of the polyethylene materials being com-
pared, as well as the respective cup designs, fixation type 
and follow-up times (Fig. 6).19
Knee arthroplasty
Robertsson et al published the first peer-reviewed study 
based on the NARA knee dataset, comparing the national 
knee registers in terms of patient characteristics, diagnos-
tic indication for the surgeries and operation techniques. 
The study showed considerable differences between the 
countries. Norway had the lowest number of procedures 
per hospital: less than half that of Sweden and Denmark. 
The preferences for implant brands varied and only three 
total brands, and one unicompartmental brand, were 
common in all three countries. Use of the patellar button 
for total knee arthroplasty (TKA) was popular in Denmark 
(76%) but not in Norway (11%) or Sweden (14%). Unce-
mented or hybrid fixation of components was also more 
frequent in Denmark (22%) than in Norway (14%) and 
Sweden (2%). The authors concluded that further classifi-
cation and standardization work was needed to permit 
more elaborate studies.20
Niemeläinen et al compared the incidences of knee 
arthroplasty among the four Nordic countries. Using the 
NARA database, they analysed the differences between 
age and sex groups. They included patients aged > 30 
years who were operated with TKA or unicompartmental 
knee arthroplasty (UKA) during the period 1997 to 2012. 
The average annual increase in the incidence of TKA was 
statistically significant in all countries. The incidence of 
TKA was higher in women than in men in all four coun-
tries. It was highest in Finland in patients aged ⩾ 65 years. 
At the end of the study period in 2012, Finland’s total inci-
dence was double that of Norway, 1.3 times that of Swe-
den and 1.4 times that of Denmark. The incidence was 
lowest in the youngest age groups (< 65 years) in all four 
countries. The proportional increase in incidence was 
highest in patients who were aged < 65 years. The authors 
concluded that the incidence of knee arthroplasty steadily 
increased in the four countries over the study period. The 
differences between the countries were considerable, 
with the highest incidence being in Finland. Patients aged 
⩾ 65 years contributed to most of the total incidence of 
knee arthroplasty.21
Badawy et al assessed 14 496 cases of cemented medial 
Oxford III UKA in 126 hospitals in the four countries from 
2000 to 2012. Hospitals were divided by quartiles into four 
annual procedure volume groups (⩽ 11, 12 to 23, 24 to 
43 and ⩾ 44). They concluded that low volume hospitals 
performing ⩽ 11 Oxford III UKAs per year were associated 
with an increased risk of revision compared with higher 
volume hospitals, and unexplained pain as the revision 
cause was more common in low volume hospitals.22
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Fig. 5 Cox survival analysis with adjustment for age, sex, time 
period, and diagnosis, and with any revision of the implant as 
endpoint. RR = 1.4 (CI: 1.3 to 1.5; p < 0.001).
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Shoulder arthroplasty
The first peer-reviewed publication based on the NARA 
shoulder database was presented by Rasmussen et al. This 
study presented the successful merge of data from the 
Nordic national registers into one common dataset; how-
ever, the set of details was reduced. They found consider-
able differences between Sweden, Denmark and Norway 
regarding the incidence and demographics of shoulder 
arthroplasty. For example, the average incidence in the 
studied period was different, with 13.3/100 000 per year 
in Denmark, 7.1/100 000 in Norway and 9.1/100 000 in 
Sweden (p < 0.001). The proportion of women was 66% 
in Sweden, 69% in Denmark and 72% in Norway (p < 
0.001). The mean age was 69 years in Denmark and Swe-
den and 70 years in Norway (p < 0.001).23
Recently, Rasmussen et al found that resurfacing shoul-
der hemi-arthroplasty and stemmed hemi-arthroplasty 
had an increased risk of revision compared with anatomi-
cal total shoulder arthroplasty.24 Lehtimäki et al found fur-
ther that the overall mid-term risk of revision after reverse 
shoulder arthroplasty for rotator cuff tear arthropathy was 
low (5%). The most common reason for early revision was 
infection. Male sex was associated with a significantly 
increased risk of revision.25
Overall
Currently there are 31 published peer-reviewed research 
papers based on NARA databases. Twenty manuscripts 
have either been submitted or are in preparation, with a 
focus on, for example, dual mobility THA devices, revision 
due to dislocation after THA, and duration of thrombo-
prophylaxis and THA mortality study with included co-
morbidity data. In addition, a collaboration project with 
the Dutch Arthroplasty Register has been initiated. The 
amount of peer-reviewed publications based on the NARA 
hip database is higher than that of the NARA knee data-
base. The harmonization of the NARA knee database has 
taken longer compared with that of the NARA hip data-
base. The quality of the data in the NARA minimal datasets 
is as good as the national registers are able to provide. The 
NARA shoulder dataset is much younger than that in hips 
and knees; therefore, there are still fewer publications.
0
A
0.94
0.96
0.98
1
2 4 6 8 0
0.94
0.96
0.98
1
2 4 6 8 0
B
0.94
0.96
0.98
1
2 4 6 8 0
0.94
0.96
0.98
1
Cumulative survival
– all cemented, all causes
– all cemented,
aseptic loosening – ZCA, all causes – ZCA, aseptic loosening
2 4 6 8
p = 1.0p = 0.8 p = 0.008 p < 0.001
0
C
0.94
0.96
0.98
1
2 4 6 8 0
0.94
0.96
0.98
1
2 4 6 8 0
D
0.94
0.96
0.98
1
2 4 6 8 0
0.94
0.96
0.98
1
– Reflection, all causes – Reflection, aseptic loosening – Charnley, all causes – Charnley, aseptic loosening
2 4 6 8
p = 0.3p = 0.3p < 0.001p < 0.001
XLPE
CPE
Fig. 6 Kaplan-Meier cumulative survival curves with 95% confidence intervals for all cemented designs (panel A), ZCA (B), Reflection 
All Poly (C), and Charnley Elite Ogee/Marathon (D) cups. The follow-up time ended when there were 100 cases at risk in the smallest 
group (always XLPE). P-values from log-rank test.
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dataset and variable definitions, and merge data. Most 
important for the continuous success is respectful open 
discussions during meetings and the willingness to com-
promise. In addition, the group has to follow the rules of 
code of conduct for research integrity. The collaboration 
was also successful because the group was able to initiate 
a number of research projects and provide answers to 
clinically relevant questions. Several specific goals, set up 
in 2007, have been achieved and new ones have emerged 
in the meantime.
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Discussion and perspectives
The primary aim of NARA is to improve the quality of 
research and thereby enhance the possibility for quality 
improvement with arthroplasty surgery. To assess to what 
extent NARA has succeeded in this mission is not straightfor-
ward. The collaboration has yielded a large body of research 
addressing clinically relevant questions. Through the respec-
tive registers network of orthopaedic surgeons, knowledge 
generated from these studies have been discussed at local, 
regional, national and international levels. We strongly 
believe that this has contributed to several changes in 
research and clinical practice as exemplified below.
Through our collaboration with regular meetings and 
networking, the data quality in the respective national reg-
istries has improved.26 Thus, a more valid basis for quality 
monitoring and research has been achieved. Variations in 
variable definitions and reporting standards have been dis-
cussed, resulting in a minimum dataset with common vari-
able definitions and standards for reporting. For example, 
before NARA, various calculation methods on complete-
ness of registration and revision outcome have been used. 
Through our internal collaboration, initiatives have been 
taken in order to improve registration systems in the Dan-
ish and Finish registers using experience from Sweden and 
Norway. The Finish registration system was restructured 
and the register has passed from a paper-based to an elec-
tronic registration system. Currently, implant data are 
gathered electronically using reference code reading from 
all hospitals in Finland. A similar system is under recon-
struction in Denmark with initial funding from NARA. Thus, 
a substantial work on harmonization of implant reporting 
and data collection in general has been done.
NARA collaborates closely with organizations outside 
the Nordic countries, for example with ISAR (International 
Society of Arthroplasty Registries), ICOR (International Con-
sortium of Orthopaedic Registries) and NORE (Network 
Orthopaedic Registries of Europe). NARA also contributes 
to quality improvement through research projects answer-
ing clinically important and up-to-date questions and con-
siderations. Our publications have already significantly 
affected clinical practice. For example, metal-on-metal THA 
and resurfacing arthroplasty have been abandoned due to 
increased revision risk.4,5 Further, the use of uncemented 
THA in elderly patients has decreased significantly, at least 
in Finland.7 NARA projects have further contributed to the 
education of young researchers and awareness of evidence-
based decision-making. The group received a large grant 
from the NordForsk for the period 2014 to 2016.
Conclusion
In conclusion, the NARA collaboration has been successful 
because countries were able to agree on a common 
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